Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
TRC autologous bone marrow cells
- Development stage
- Unknown
- Lead developer
- Vericel
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Implant
01
Overview
TRC autologous bone marrow cells (Tissue Repair Cells) are a cell-based biologic therapy consisting of autologous bone marrow progenitor cells expanded ex vivo using the Aastrom Replicell™ system. Developed by Aastrom Biosciences (now Vericel), this therapy leverages the osteogenic and regenerative potential of expanded progenitor cells to promote bone healing. The product contains a mixture of stem and progenitor cells, including mesenchymal stem cells and hematopoietic progenitor cells, which contribute to bone formation and vascularization. It has been investigated in Phase I/II clinical trials for the surgical treatment of non-hypertrophic pseudoarthrosis and complex fractures of long bones, demonstrating safety and efficacy in promoting bone callus formation.
- Other names
- Tissue Repair CellsAastrom Tissue Repair Cellsautologous bone marrow progenitor cellsexpanded autologous bone marrow cells
Beyond the preview
Go deeper on TRC autologous bone marrow cells.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on TRC autologous bone marrow cells.